HWM
GMAB icon

Hemington Wealth Management’s Genmab GMAB Stock Holding History

Hemington Wealth Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$0 Buy
+19
New +$463 ﹤0.01% 1604

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hemington Wealth Management's GMAB Position: Q3 2025 in Review

Hemington Wealth Management opened a new position in Genmab (GMAB) in Q3 2025: 19 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1604 among its holdings.

252 funds tracked by Wall St. Rank hold GMAB as of Q3 2025.

  • Hemington Wealth Management held 19 shares of Genmab worth $0 as of Q3 2025.
  • Genmab was a new Hemington Wealth Management position in Q3 2025.
  • Genmab made up ﹤0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #1604 holding.
  • 252 funds tracked by Wall St. Rank held Genmab as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.